Carriage rates of Neisseria meningitides serogroups: determination among freshmen conscripts before vaccination
,
Abstract
Background and Objectives: Neisseria meningitidis is transmitted from person-to-person. Thus, close contact with a healthy carrier can facilitate the spread of the bacteria and lead to life-threatening meningococcal disease. The aim of this study was to identify oropharyngeal carriers of N. meningitidis in volunteers preparing for military service before vaccination.
Materials and Methods: In a cross-sectional study, 226 volunteers entering military service were referred to the Shemiranat Health Center for meningococcal vaccination and assayed. Before vaccination, the participants underwent sampling of the throat using separate swabs. Thayer-Martin Agar medium and microbiological standard methods were used for culture and isolation of the organisms. The bacterial isolates were subjected to DNA extraction and polymerase chain reaction. The obtained data were descriptively analyzed.
Results: Out of the 226 (100%) young volunteers, only 18 (8%) yielded Gram-negative diplococci. The results showed the presence of N. meningitidis (carriage rate: 8%) in their oropharyngeal regions. The isolated serogroups were C, A, Y, W-135, and X with frequencies of 50, 22.2, 16.6, 5.5, and 5.5, respectively.
Discussion: This study showed that the carriage rate in young volunteers for military service is around 8% before vaccination. Although the rates for serogroups A and C were dominant, the existence of serogroups Y and W indicate the necessary revision of the A/C vaccine. More research is needed to determine serogroup diversity and decrease the risk of meningococcal disease in individual groups.
Johswich KO, McCaw SE, Islam E, Sintsova A, Gu A, Shively JE et al. In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mu- cosa. PLoS Pathog 2013;9:e1003509.
Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria menin- gitidis. Lancet 2007;369:2196-2210.
Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine 2012;30 (Suppl
:B3-B9.
Stefanelli P, Fazio C, Neri A, Isola P, Sani S, Marelli P et al. Cluster of invasive Neisseria meningitidis infec- tions on a cruise ship, Italy, October 2012. Euro Sur- veill 2012;17:20336.
Stephens DS, Edwards KM, McKee KT. Meningo- coccal group Y disease in children. Pediatr Infect Dis 1984; :523-5.
Hayakawa K, Itoda I, Shimuta K, Takahashi H, Ohni- shi M. Urethritis caused by novel Neisseria meningiti- dis serogroup W in man who has sex with men, Japan. Emerg Infect Dis 2014; 20:1585-7.
Bousquet A, Janvier F, Abi R, Larreche S, Merens A.Neisseria meningitidis urethritis. Med Mal Infect 2012;42:444-445.
Almeida-Gonzalez L, Franco-Paredes C, Perez LF, Santos-Preciado JI. Meningococcal disease caused by Neisseria meningitidis: epidemiological, clinical, and preventive perspectives. Salud Publica Mex 2004;46:438-450.
Christensen H, May M, Bowen L, Hichman M, Trot- ter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis 2010;10:853–861.
Chang Q, Tzeng YL, Stephens DS. Meningococcal disease: changes in epidemiology and prevention. Clin Epidemiol 2012; 4:237-245.
Korzeniewski K, Skoczynska A, Guzek A, Konior M, Chcialowski A, Wasko I et al. Effectiveness of immu- noprophylaxis in suppressing carriage of Neisseria meningitidis in the military environment. Adv Exp Med Biol 2015;836:19-28.
Stephens DS. Uncloaking the meningococcus: dynam- ics of carriage and disease. Lancet 1999; 353:941-942
Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med 2001; 344:1378-1388.
Wang Q, Shao Z, Wang X, Gao Y, Li M, Xu L et al.Genetic study of capsular switching between Neisse- ria meningitidis sequence type 7 serogroup A and C strains. Infect Immun 2010; 78:3883-3888.
Makela PH, Kayhty H, Weekstrom P, et al. Effect of group A Meningococcal vaccine in army recruits in Finland. Lancet 1975; 2:883-886.
Keiser PB, Hamilton L, Broderick M. U.S. military fa- talities due to Neisseria meningitidis: case reports and historical perspective. Mil Med 2011;176:308-311.
Caugant DA, Hoiby EA, Magnus P, Scheel O, Hoel T, Bjune G et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol 1994; 32:323-30.
Ataee RA, Mehrabi Tavana A, Ghorbani GH, Mosavi SA, Karimi ZA, Hajia M. Recurrent Meningococcal meningitis in an Iranian Cocnscript: A brief report. Clin Microbiol Newsletter 2005; 27: 136-137.
Qubanalizadegan M, Ranjbar R, Ataee R.A, Hajia M, Goodarzi Z, Farshad S, Jonadi Jafari N et al. Specific PCR assay for rapid and direct detection of Nesseria meningitidis in cerebrospinal fluid specimens. Iran J Public Health 2010; 39: 45-50.
Taha MK. Simultaneous approach for nonculture PCRbased identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol 2000; 38: 855-857.
Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning a laboratory manual. Third Edition. New York: Cold spring Harbor Laboratory Press; 2001.
Mehrabi Tavana A, Ataee R A. Meningococcal Men-ingitis Control in Iran: five year Comparative Study 2000- 2004. J Med Sci 2009; 9(1): 51-54.
Ataee RA, Mehrabi Tavana A, Ghorbani GH, Hossaini Shokooh SJ, Hajia M, and Karami A. Serotyping of Neisseria meninigitidis in conscripts with meningitis admitted to five military hospital in Tehran between September 2004 and September 2006. Journal of Army University of Medical Sciences of the Iran (Persian)2006; 4: 771- 770.
Ataee RA, Mehrabi Tavana A, Ghorbani GH, Karimi Zarchi AA. Hajia M, Hosseini SMJ, Mousavi SA, and et al. Determination of bacterial Etiology of CSF of Patients with meningitis at four Military Hospital in Tehran between 2003 and 2005. Iran J Mil Med 2005;7: 49-56.
Lansac N, Picard FJ, Menard C, Boissinot M, Ouellette 9. M, Roy PH, et al. Novel genus specific PCR based as¬say for rapid identification of Neisseria species and Neisseria meningitidis. Eur J Clin Microbiol Infect Dis 2000; 19: 443-451.
MehrabiTavana A, Ataee RA, Gouya M, Parhisgar SH, Hosseini Shokoh MJ, et al. The effects of vaccination against meningococcal meningitis in I.R. Iran military forces during the years 1981 to 2009. Annual of Mil- itary and Health Sciences Research (Persian) 2010;8:186-192.
Alborzi A, Oskoee S, Pourabbas B, Alborzi S, Astaneh B, Gooya MM et al. Meningococcal carrier rate before and after hajj pilgrimage: effect of single dose cipro- floxacin on carriage. East Mediterr Health J 2008;14:277-282.
Valipour M, Piroozmand A, Khorshidi A, Akbari H, Mirzaee H. Identification of serological groups A, B, C, W135, Y, X Neisseria meningitidis carriers by mul- tiplex PCR in the nasopharynx of students in Kashan during 2011-2012. Feyz, Journal of Kashan University of Medical Sciences (Persian) 2013; 17(2): 181-187.
de Moraes JC, Kemp B, de Lemos AP, Outeiro Gor- la MC, Lemes Marques EG, Ferreira MC et al. prev- alence, risk factors and molecular characteristics of meningococcal carriage among brazilian adolescents. Pediatr Infect Dis J 2015; 34:1197-1202.
Laver JR, Hughes SE, Read RC. Neisserial molecular adaptations to the nasopharyngeal niche. Adv Microb Physiol 2015; 66:323-55.
Gianchecchi E, Torelli A, Piccini G, Piccirella S, Mon- tomoli E. Neisseria meningitidis infection: who, when and where? Expert Rev Anti Infect Ther 2015; 13:1249-1263.
Turhan V, Acar A, Kilic A, Budak S, Oncul O, Haz- nedaroglu T et al. Meningococcemia and meningitis due to Neisseria meningitidis W135 developed in two cases vaccinated with bivalent (A/C) eningococcal vaccine. Mikrobiyol Bul 2010; 44:473-478.
| Files | ||
| Issue | Vol 8 No 3 (2016) | |
| Section | Articles | |
| Keywords | ||
| Conscripts Healthy carrier PCR Neisseria meningitidis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
